Exane Derivatives’s Chubb CB Stock Holding History

Exane Derivatives’s Portfolio CB Stock Details CB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$804K	Sell	4,090 -1,334	-25%	-$275K	0.46%	52
2022 Q1	$1.16M	Buy	5,424 +116	+2%	+$23.6K	0.33%	72
2021 Q4	$1.03M	Sell	5,308 -2,076	-28%	-$390K	0.25%	87
2021 Q3	$1.28M	Sell	7,384 -447	-6%	-$78.4K	0.31%	70
2021 Q2	$1.28M	Buy	7,831 +419	+6%	+$69.4K	0.29%	78
2021 Q1	$1.17M	Buy	7,412 +365	+5%	+$58.8K	0.33%	68
2020 Q4	$1.08M	Buy	+7,047	New	+$988K	0.32%	76

Other funds holding CB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Exane Derivatives's CB Position: Q2 2022 in Review

Exane Derivatives reduced its Chubb (CB) stake by 25% in Q2 2022, selling an estimated $275K and leaving 4,090 shares worth $804K. The position accounts for 0.46% of the portfolio, ranked #52.

Exane Derivatives first reported a position in CB in Q4 2020 and has held it in 7 quarters since. The position peaked at $1.28M in Q3 2021. 1,403 funds tracked by Wall St. Rank hold CB as of Q2 2022.

Exane Derivatives held 4,090 shares of Chubb worth $804K as of Q2 2022.
Exane Derivatives sold 1,334 Chubb shares in Q2 2022, an estimated $275K.
Chubb made up 0.46% of Exane Derivatives's portfolio in Q2 2022, its #52 holding.
Exane Derivatives first reported a position in Chubb in Q4 2020 and has held it in 7 quarters since.
Exane Derivatives's Chubb position peaked at $1.28M in Q3 2021.
1,403 funds tracked by Wall St. Rank held Chubb as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.